Yuko Tsuchiya‐Kawano

Clinical impact of probiotics on the efficacy of <scp>anti‐PD</scp>‐1 monotherapy in patients with nonsmall cell lung cancer: A multicenter retrospective survival analysis study with inverse probability of treatment weighting

Kazuki Takada, Mototsugu Shimokawa, Shinkichi Takamori et al. · International Journal of Cancer · 2021 · 96 citations · Full text

Medicine, Oncology, Pharmacotherapy +14

Assessment of the albumin-bilirubin grade as a prognostic factor in patients with non-small-cell lung cancer receiving anti-PD-1-based therapy

Kazuki Takada, Shinkichi Takamori, Mototsugu Shimokawa et al. · ESMO Open · 2021 · 34 citations · Full text

Medicine, Oncology, Chemotherapy +13

A propensity score-matched analysis of the impact of statin therapy on the outcomes of patients with non-small-cell lung cancer receiving anti-PD-1 monotherapy: a multicenter retrospective study

Kazuki Takada, Mototsugu Shimokawa, Shinkichi Takamori et al. · BMC Cancer · 2022 · 31 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Association of thyroid transcription factor-1 (TTF-1) expression with efficacy of PD-1/PD-L1 inhibitors plus pemetrexed and platinum chemotherapy in advanced non-squamous non-small cell lung cancer

Ritsu Ibusuki, Yasuto Yoneshima, Mikiko Hashisako et al. · Translational Lung Cancer Research · 2022 · 23 citations · Full text

Medicine, Oncology, Pharmacology +17

Antibiotic-dependent effect of probiotics in patients with non-small cell lung cancer treated with PD-1 checkpoint blockade

Kazuki Takada, Sebastiano Buti, Melissa Bersanelli et al. · European Journal of Cancer · 2022 · 22 citations

Medicine, Immunology, Oncology +16